Last edition
News about "Pharmaceutical compliance"
Health Ministry Ends Cough Syrup Sale Exemption in Villages
The Union Ministry of Health and Family Welfare has amended the Drugs Rules, 1945, withdrawing the exemption for cough syrup sales in small villages. The move strengthens regulatory oversight and aims to improve monitoring, safety, and control of cough syrup distribution across India.
Pharmaceutical Compliance | 16/06/2026 | By News Bureau
India Brings Pregabalin under Schedule H1 to Curb Misuse and Strengthen Drug Regulation
Union Health Ministry has brought Pregabalin under Schedule H1 to strengthen prescription monitoring, regulate supply chains, and prevent misuse and unauthorised access to the widely used neurological medicine.
Pharmaceutical Compliance | 25/05/2026 | By News Bureau | 155
US FDA Proposes Excluding Semaglutide, Tirzepatide and Liraglutide from 503B Bulks List
The US Food and Drug Administration (FDA) proposes excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, citing no clinical need for compounding these GLP-1 drugs by outsourcing facilities.
Pharmaceutical Compliance | 04/05/2026 | By News Bureau | 101
Ipsen Discontinues Tazverik for Certain Cancer Uses
In addition to withdrawing Tazverik from the market, Ipsen has initiated steps to stop treatment with tazemetostat for all patients currently enrolled in the ongoing SYMPHONY-1 trial. All participants will receive standard of care, lenalidomide plus rituximab only.
Pharmaceutical Compliance | 09/03/2026 | By News Bureau | 166
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy